Merit Medical Systems Inc MMSI
We take great care to ensure that the data presented and summarized in this overview for MERIT MEDICAL SYSTEMS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MMSI
View all-
Black Rock Inc. New York, NY8.91MShares$849 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.57MShares$626 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.27MShares$216 Million3.61% of portfolio
-
State Street Corp Boston, MA2.19MShares$209 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.79MShares$170 Million0.04% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA1.77MShares$168 Million0.74% of portfolio
-
Macquarie Group LTD Australia, C31.45MShares$138 Million0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA1.4MShares$133 Million0.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx1.27MShares$121 Million2.65% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.15MShares$110 Million0.03% of portfolio
Latest Institutional Activity in MMSI
Top Purchases
Top Sells
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
Insider Transactions at MMSI
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 05
2025
|
Fred P Lampropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-0.95%
|
$950,000
$95.19 P/Share
|
Jun 02
2025
|
Michael R Mcdonnell |
SELL
Open market or private sale
|
Direct |
1,750
-21.49%
|
$164,500
$94.51 P/Share
|
Jun 02
2025
|
Michel James Voigt CHIEF HUMAN RESOURCES OFFICER |
SELL
Bona fide gift
|
Direct |
55
-0.25%
|
-
|
May 30
2025
|
David Floyd |
SELL
Open market or private sale
|
Indirect |
3,515
-41.87%
|
$330,410
$94.16 P/Share
|
May 30
2025
|
Michael R Mcdonnell |
SELL
Open market or private sale
|
Direct |
1,750
-17.69%
|
$164,500
$94.3 P/Share
|
May 30
2025
|
Fred P Lampropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-0.94%
|
$950,000
$95.12 P/Share
|
May 27
2025
|
Fred P Lampropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-1.84%
|
$1,920,000
$96.54 P/Share
|
May 15
2025
|
Thomas James Gunderson |
BUY
Grant, award, or other acquisition
|
Direct |
2,152
+5.64%
|
-
|
May 15
2025
|
F. Ann Millner |
SELL
Open market or private sale
|
Direct |
21,250
-38.09%
|
$2,040,000
$96.47 P/Share
|
May 15
2025
|
F. Ann Millner |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+27.58%
|
$1,105,000
$52.17 P/Share
|
May 15
2025
|
F. Ann Millner |
BUY
Grant, award, or other acquisition
|
Direct |
2,152
+5.86%
|
-
|
May 15
2025
|
Laura S. Kaiser |
BUY
Grant, award, or other acquisition
|
Direct |
2,152
+17.86%
|
-
|
May 15
2025
|
Michael R Mcdonnell |
BUY
Grant, award, or other acquisition
|
Direct |
2,152
+17.86%
|
-
|
May 15
2025
|
Lynne Ward |
BUY
Grant, award, or other acquisition
|
Direct |
2,152
+14.38%
|
-
|
May 15
2025
|
David Floyd |
BUY
Grant, award, or other acquisition
|
Direct |
4,304
+16.32%
|
-
|
May 15
2025
|
Stephen C. Evans |
BUY
Grant, award, or other acquisition
|
Direct |
2,152
+24.02%
|
-
|
May 15
2025
|
Lonny J Carpenter |
BUY
Grant, award, or other acquisition
|
Direct |
2,152
+11.03%
|
-
|
May 15
2025
|
Silvia Perez |
BUY
Grant, award, or other acquisition
|
Direct |
2,152
+31.95%
|
-
|
Apr 01
2025
|
Neil Peterson CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-14.98%
|
$520,000
$104.53 P/Share
|
Apr 01
2025
|
Neil Peterson CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+13.03%
|
$270,000
$54.4 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 155K shares |
---|---|
Exercise of conversion of derivative security | 242K shares |
Payment of exercise price or tax liability | 76.1K shares |
---|---|
Open market or private sale | 269K shares |
Bona fide gift | 5.42K shares |